Following a high-level policy dialogue between the Director-General of WHO and China’s National Administration of Traditional Chinese Medicine (NATCM) in Geneva on 17 January 2022, WHO decided to convene a meeting of experts to evaluate the role of Traditional Chinese Medicine (TCM) in the treatment of COVID-19. The subsequent Expert Meeting on Evaluation of Traditional Chinese Medicine in the Treatment of COVID-19 was held virtually from 28 February to 02 March 2022 from 13:00 to 16:00 Central European Time each day.  

The 21 international experts from the six WHO regions included five members of the WHO Expert Advisory Panel, representatives of eight WHO collaborating centres, three members of the WHO International Regulatory Cooperation for Herbal Medicines (IRCH), and members of the China Academy of Chinese Medical Sciences. Technical staff from WHO headquarters, regional and country offices also attended the meeting.